APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galidesivir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Galidesivir Industry Growth and Trends Forecast to 2032

2 January 202697 pages

Choose your research edition.

Industry ResearchGalidesivir Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Galidesivir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Galidesivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galidesivir Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Galidesivir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Galidesivir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galidesivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Galidesivir include BioCryst Pharmaceuticals, Cayman Chemical, ChemScene, CliniSciences, Taiclone and Xi'an Henrikang Biotech Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Galidesivir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Galidesivir market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Galidesivir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Galidesivir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Galidesivir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Galidesivir Market by Company

BioCryst Pharmaceuticals

Cayman Chemical

ChemScene

CliniSciences

Taiclone

Xi'an Henrikang Biotech Co.

Galidesivir Segment by Type

Galidesivir Powder

Galidesivir Hydrochloride

Galidesivir Segment by Application

Yellow Fever

Marburg Virus Disease

Filovirus Infections/Ebola Virus Infection

Galidesivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galidesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galidesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galidesivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Galidesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Galidesivir Powder Table 2. Major Company of Galidesivir Hydrochloride Table 3. Global Galidesivir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Galidesivir Sales by Type (2021-2026) & (Tons) Table 5. Global Galidesivir Sales Market Share in Volume by Type (2021-2026) Table 6. Global Galidesivir Sales by Type (2021-2026) & (US$ Million) Table 7. Global Galidesivir Sales Market Share in Value by Type (2021-2026) Table 8. Global Galidesivir Price by Type (2021-2026) & (US$/Kg) Table 9. Global Galidesivir Sales by Type (2027-2032) & (Tons) Table 10. Global Galidesivir Sales Market Share in Volume by Type (2027-2032) Table 11. Global Galidesivir Sales by Type (2027-2032) & (US$ Million) Table 12. Global Galidesivir Sales Market Share in Value by Type (2027-2032) Table 13. Global Galidesivir Price by Type (2027-2032) & (US$/Kg) Table 14. North America Galidesivir Sales by Type (2021-2026) & (Tons) Table 15. North America Galidesivir Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Galidesivir Sales by Type (2021-2026) & (Tons) Table 17. Europe Galidesivir Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Galidesivir Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Galidesivir Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Galidesivir Sales by Type (2021-2026) & (Tons) Table 21. Latin America Galidesivir Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Galidesivir Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Galidesivir Sales by Type (2021-2026) & (US$ Million) Table 24. Galidesivir Industry Trends Table 25. Galidesivir Industry Drivers Table 26. Galidesivir Industry Opportunities and Challenges Table 27. Galidesivir Industry Restraints Table 28. Global Galidesivir Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Galidesivir Revenue Market Share by Company (2021-2026) Table 30. Global Galidesivir Sales by Company (2021-2026) & (Tons) Table 31. Global Galidesivir Sales Share by Company (2021-2026) Table 32. Global Galidesivir Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Galidesivir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Galidesivir Major Company Production Sites and Headquarters Table 35. Global Galidesivir Company, Product Type & Application Table 36. Global Galidesivir Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Galidesivir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Galidesivir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Galidesivir Sales by Region (2021-2026) & (Tons) Table 41. Global Galidesivir Sales Market Share in Volume by Region (2021-2026) Table 42. Global Galidesivir Sales by Region (2021-2026) & (US$ Million) Table 43. Global Galidesivir Sales Market Share in Value by Region (2021-2026) Table 44. Global Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Galidesivir Sales by Region (2027-2032) & (Tons) Table 46. Global Galidesivir Sales Market Share in Volume by Region (2027-2032) Table 47. Global Galidesivir Sales by Region (2027-2032) & (US$ Million) Table 48. Global Galidesivir Sales Market Share in Value by Region (2027-2032) Table 49. Global Galidesivir Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Galidesivir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Galidesivir Sales by Application (2021-2026) & (Tons) Table 52. Global Galidesivir Sales Market Share in Volume by Application (2021-2026) Table 53. Global Galidesivir Sales by Application (2021-2026) & (US$ Million) Table 54. Global Galidesivir Sales Market Share in Value by Application (2021-2026) Table 55. Global Galidesivir Price by Application (2021-2026) & (US$/Kg) Table 56. Global Galidesivir Sales by Application (2027-2032) & (Tons) Table 57. Global Galidesivir Sales Market Share in Volume by Application (2027-2032) Table 58. Global Galidesivir Sales by Application (2027-2032) & (US$ Million) Table 59. Global Galidesivir Sales Market Share in Value by Application (2027-2032) Table 60. Global Galidesivir Price by Application (2027-2032) & (US$/Kg) Table 61. North America Galidesivir Sales by Application (2021-2026) & (Tons) Table 62. North America Galidesivir Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Galidesivir Sales by Application (2021-2026) & (Tons) Table 64. Europe Galidesivir Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Galidesivir Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Galidesivir Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Galidesivir Sales by Application (2021-2026) & (Tons) Table 68. Latin America Galidesivir Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Galidesivir Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Galidesivir Sales by Application (2021-2026) & (US$ Million) Table 71. BioCryst Pharmaceuticals Company Information Table 72. BioCryst Pharmaceuticals Business Overview Table 73. BioCryst Pharmaceuticals Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. BioCryst Pharmaceuticals Galidesivir Product Portfolio Table 75. BioCryst Pharmaceuticals Recent Development Table 76. Cayman Chemical Company Information Table 77. Cayman Chemical Business Overview Table 78. Cayman Chemical Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Cayman Chemical Galidesivir Product Portfolio Table 80. Cayman Chemical Recent Development Table 81. ChemScene Company Information Table 82. ChemScene Business Overview Table 83. ChemScene Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. ChemScene Galidesivir Product Portfolio Table 85. ChemScene Recent Development Table 86. CliniSciences Company Information Table 87. CliniSciences Business Overview Table 88. CliniSciences Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. CliniSciences Galidesivir Product Portfolio Table 90. CliniSciences Recent Development Table 91. Taiclone Company Information Table 92. Taiclone Business Overview Table 93. Taiclone Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Taiclone Galidesivir Product Portfolio Table 95. Taiclone Recent Development Table 96. Xi'an Henrikang Biotech Co. Company Information Table 97. Xi'an Henrikang Biotech Co. Business Overview Table 98. Xi'an Henrikang Biotech Co. Galidesivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio Table 100. Xi'an Henrikang Biotech Co. Recent Development Table 101. North America Galidesivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 102. North America Galidesivir Sales by Country (2021-2026) & (Tons) Table 103. North America Galidesivir Sales Market Share by Country (2021-2026) Table 104. North America Galidesivir Sales Forecast by Country (2027-2032) & (Tons) Table 105. North America Galidesivir Sales Market Share Forecast by Country (2027-2032) Table 106. North America Galidesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Galidesivir Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Galidesivir Market Share by Country (2021-2026) Table 109. North America Galidesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Galidesivir Market Share Forecast by Country (2027-2032) Table 111. Europe Galidesivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 112. Europe Galidesivir Sales by Country (2021-2026) & (Tons) Table 113. Europe Galidesivir Sales Market Share by Country (2021-2026) Table 114. Europe Galidesivir Sales Forecast by Country (2027-2032) & (Tons) Table 115. Europe Galidesivir Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Galidesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Galidesivir Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Galidesivir Market Share by Country (2021-2026) Table 119. Europe Galidesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Galidesivir Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Galidesivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Galidesivir Sales by Country (2021-2026) & (Tons) Table 123. Asia-Pacific Galidesivir Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Galidesivir Sales Forecast by Country (2027-2032) & (Tons) Table 125. Asia-Pacific Galidesivir Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Galidesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Galidesivir Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Galidesivir Market Share by Country (2021-2026) Table 129. Asia-Pacific Galidesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Galidesivir Market Share Forecast by Country (2027-2032) Table 131. Latin America Galidesivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Latin America Galidesivir Sales by Country (2021-2026) & (Tons) Table 133. Latin America Galidesivir Sales Market Share by Country (2021-2026) Table 134. Latin America Galidesivir Sales Forecast by Country (2027-2032) & (Tons) Table 135. Latin America Galidesivir Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Galidesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Galidesivir Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Galidesivir Market Share by Country (2021-2026) Table 139. Latin America Galidesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Galidesivir Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Galidesivir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Galidesivir Sales by Country (2021-2026) & (Tons) Table 143. Middle East and Africa Galidesivir Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Galidesivir Sales Forecast by Country (2027-2032) & (Tons) Table 145. Middle East and Africa Galidesivir Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Galidesivir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Galidesivir Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Galidesivir Market Share by Country (2021-2026) Table 149. Middle East and Africa Galidesivir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Galidesivir Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Galidesivir Distributors List Table 154. Galidesivir Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Galidesivir Image Figure 2. Global Galidesivir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galidesivir Market Size (2021-2032) & (US$ Million) Figure 4. Global Galidesivir Sales (2021-2032) & (Tons) Figure 5. Galidesivir Powder Image Figure 6. Global Galidesivir Powder Sales YoY Growth (2021-2032) & (Tons) Figure 7. Galidesivir Hydrochloride Image Figure 8. Global Galidesivir Hydrochloride Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Galidesivir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Galidesivir Market Share by Type 2025 VS 2032 Figure 11. North America Galidesivir Sales Market Share in Volume by Type in 2025 Figure 12. North America Galidesivir Sales Market Share in Value by Type in 2025 Figure 13. Europe Galidesivir Sales Market Share in Volume by Type in 2025 Figure 14. Europe Galidesivir Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Galidesivir Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Galidesivir Sales Market Share in Value by Type in 2025 Figure 17. Latin America Galidesivir Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Galidesivir Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Galidesivir Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Galidesivir Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Galidesivir Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Yellow Fever Image Figure 24. Global Yellow Fever Sales YoY Growth (2021-2032) & (Tons) Figure 25. Marburg Virus Disease Image Figure 26. Global Marburg Virus Disease Sales YoY Growth (2021-2032) & (Tons) Figure 27. Filovirus Infections/Ebola Virus Infection Image Figure 28. Global Filovirus Infections/Ebola Virus Infection Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Galidesivir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Galidesivir Market Share by Application 2025 VS 2032 Figure 31. North America Galidesivir Sales Market Share in Volume by Application in 2025 Figure 32. North America Galidesivir Sales Market Share in Value by Application in 2025 Figure 33. Europe Galidesivir Sales Market Share in Volume by Application in 2025 Figure 34. Europe Galidesivir Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Galidesivir Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Galidesivir Sales Market Share in Value by Application in 2025 Figure 37. Latin America Galidesivir Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Galidesivir Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Galidesivir Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Galidesivir Sales Market Share in Value by Application in 2025 Figure 41. North America Galidesivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Galidesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Galidesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Galidesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Galidesivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Galidesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Galidesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Galidesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Galidesivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Galidesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Galidesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Galidesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Galidesivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Galidesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Galidesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Galidesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Galidesivir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Galidesivir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Galidesivir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Galidesivir Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Galidesivir Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Galidesivir Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Galidesivir Powder
  • Galidesivir Hydrochloride
Applications
  • Yellow Fever
  • Marburg Virus Disease
  • Filovirus Infections/Ebola Virus Infection
Companies covered
  • BioCryst Pharmaceuticals
  • Cayman Chemical
  • ChemScene
  • CliniSciences
  • Taiclone
  • Xi'an Henrikang Biotech Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Galidesivir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Galidesivir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Galidesivir Market by Type
  6. 1.3.1 Galidesivir Powder
  7. 1.3.2 Galidesivir Hydrochloride
  8. 1.4 Global Galidesivir Market Size by Type
  9. 1.4.1 Global Galidesivir Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Galidesivir Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Galidesivir Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Galidesivir Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Galidesivir Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Galidesivir Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Galidesivir Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Galidesivir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Galidesivir Industry Trends
  2. 2.2 Galidesivir Industry Drivers
  3. 2.3 Galidesivir Industry Opportunities and Challenges
  4. 2.4 Galidesivir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Galidesivir Revenue (2021-2026)
  2. 3.2 Global Top Players by Galidesivir Sales (2021-2026)
  3. 3.3 Global Top Players by Galidesivir Price (2021-2026)
  4. 3.4 Global Galidesivir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Galidesivir Major Company Production Sites & Headquarters
  6. 3.6 Global Galidesivir Company, Product Type & Application
  7. 3.7 Global Galidesivir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Galidesivir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Galidesivir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Galidesivir Tier 1, Tier 2, and Tier 3
4 Galidesivir Regional Status and Outlook
  1. 4.1 Global Galidesivir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Galidesivir Historic Market Size by Region
  3. 4.2.1 Global Galidesivir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Galidesivir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Galidesivir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Galidesivir Forecasted Market Size by Region
  7. 4.3.1 Global Galidesivir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Galidesivir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Galidesivir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Galidesivir by Application
  1. 5.1 Galidesivir Market by Application
  2. 5.1.1 Yellow Fever
  3. 5.1.2 Marburg Virus Disease
  4. 5.1.3 Filovirus Infections/Ebola Virus Infection
  5. 5.2 Global Galidesivir Market Size by Application
  6. 5.2.1 Global Galidesivir Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Galidesivir Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Galidesivir Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Galidesivir Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Galidesivir Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Galidesivir Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Galidesivir Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Galidesivir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BioCryst Pharmaceuticals
  2. 6.1.1 BioCryst Pharmaceuticals Company Information
  3. 6.1.2 BioCryst Pharmaceuticals Business Overview
  4. 6.1.3 BioCryst Pharmaceuticals Galidesivir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BioCryst Pharmaceuticals Galidesivir Product Portfolio
  6. 6.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 6.2 Cayman Chemical
  8. 6.2.1 Cayman Chemical Company Information
  9. 6.2.2 Cayman Chemical Business Overview
  10. 6.2.3 Cayman Chemical Galidesivir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cayman Chemical Galidesivir Product Portfolio
  12. 6.2.5 Cayman Chemical Recent Developments
  13. 6.3 ChemScene
  14. 6.3.1 ChemScene Company Information
  15. 6.3.2 ChemScene Business Overview
  16. 6.3.3 ChemScene Galidesivir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ChemScene Galidesivir Product Portfolio
  18. 6.3.5 ChemScene Recent Developments
  19. 6.4 CliniSciences
  20. 6.4.1 CliniSciences Company Information
  21. 6.4.2 CliniSciences Business Overview
  22. 6.4.3 CliniSciences Galidesivir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CliniSciences Galidesivir Product Portfolio
  24. 6.4.5 CliniSciences Recent Developments
  25. 6.5 Taiclone
  26. 6.5.1 Taiclone Company Information
  27. 6.5.2 Taiclone Business Overview
  28. 6.5.3 Taiclone Galidesivir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taiclone Galidesivir Product Portfolio
  30. 6.5.5 Taiclone Recent Developments
  31. 6.6 Xi'an Henrikang Biotech Co.
  32. 6.6.1 Xi'an Henrikang Biotech Co. Company Information
  33. 6.6.2 Xi'an Henrikang Biotech Co. Business Overview
  34. 6.6.3 Xi'an Henrikang Biotech Co. Galidesivir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio
  36. 6.6.5 Xi'an Henrikang Biotech Co. Recent Developments
7 North America by Country
  1. 7.1 North America Galidesivir Sales by Country
  2. 7.1.1 North America Galidesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Galidesivir Sales by Country (2021-2026)
  4. 7.1.3 North America Galidesivir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Galidesivir Market Size by Country
  6. 7.2.1 North America Galidesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Galidesivir Market Size by Country (2021-2026)
  8. 7.2.3 North America Galidesivir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Galidesivir Sales by Country
  2. 8.1.1 Europe Galidesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Galidesivir Sales by Country (2021-2026)
  4. 8.1.3 Europe Galidesivir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Galidesivir Market Size by Country
  6. 8.2.1 Europe Galidesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Galidesivir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Galidesivir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Galidesivir Sales by Country
  2. 9.1.1 Asia-Pacific Galidesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Galidesivir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Galidesivir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Galidesivir Market Size by Country
  6. 9.2.1 Asia-Pacific Galidesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Galidesivir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Galidesivir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Galidesivir Sales by Country
  2. 10.1.1 South America Galidesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Galidesivir Sales by Country (2021-2026)
  4. 10.1.3 South America Galidesivir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Galidesivir Market Size by Country
  6. 10.2.1 South America Galidesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Galidesivir Market Size by Country (2021-2026)
  8. 10.2.3 South America Galidesivir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Galidesivir Sales by Country
  2. 11.1.1 Middle East and Africa Galidesivir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Galidesivir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Galidesivir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Galidesivir Market Size by Country
  6. 11.2.1 Middle East and Africa Galidesivir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Galidesivir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Galidesivir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Galidesivir Value Chain Analysis
  2. 12.1.1 Galidesivir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Galidesivir Production Mode & Process
  7. 12.2 Galidesivir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Galidesivir Distributors
  10. 12.2.3 Galidesivir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst